Literature DB >> 11093057

Malignant transformation of ovarian endometriosis.

M Nishida1, K Watanabe, N Sato, Y Ichikawa.   

Abstract

One hundred forty-seven cases of ovarian endometriosis, encountered from 1976 to 1999 at Tsukuba University Hospital, were studied to clarify the incidence of malignant transformation. There were 18 cases (12.2%) of atypical endometriosis, among which we found a case (5.6%) of ovarian cancer arising from endometriosis not diagnosed before surgery. This is accounted for 0.7% of all ovarian endometriosis cases. Because the incidence was equal to that of the previous reports, it is most likely that the malignant change in ovarian endometriosis occurred in 0.7% of this disease. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2000        PMID: 11093057     DOI: 10.1159/000052874

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  16 in total

1.  No evidence of endometriosis within serous and mucinous tumors of the ovary.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

2.  Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers.

Authors:  William J Lowery; Joellen M Schildkraut; Liudmila Akushevich; Rex Bentley; Jeffrey R Marks; David Huntsman; Andrew Berchuck
Journal:  Int J Gynecol Cancer       Date:  2012-01       Impact factor: 3.437

3.  Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer.

Authors:  Swati Suryawanshi; Xin Huang; Esther Elishaev; Raluca A Budiu; Lixin Zhang; SungHwan Kim; Nicole Donnellan; Gina Mantia-Smaldone; Tianzhou Ma; George Tseng; Ted Lee; Suketu Mansuria; Robert P Edwards; Anda M Vlad
Journal:  Clin Cancer Res       Date:  2014-10-07       Impact factor: 12.531

4.  Endometrioid adenocarcinoma arising from endometriosis of the uterine cervix: a case report.

Authors:  Han Moie Park; Sang Soo Lee; Dae Woon Eom; Gil Hyun Kang; Sang Wook Yi; Woo Seok Sohn
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

Review 5.  Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis.

Authors:  Hiroshi Kobayashi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

6.  Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.

Authors:  Swati Suryawanshi; Anda M Vlad; Hui-Min Lin; Gina Mantia-Smaldone; Robin Laskey; Minjae Lee; Yan Lin; Nicole Donnellan; Marcia Klein-Patel; Ted Lee; Suketu Mansuria; Esther Elishaev; Raluca Budiu; Robert P Edwards; Xin Huang
Journal:  Clin Cancer Res       Date:  2013-01-29       Impact factor: 12.531

7.  Endometrioid adenocarcinoma of the ovary arising in atypical endometriosis.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

Review 8.  Screening, epidemiology, molecular biology, and treatment strategies for endometriosis-associated ovarian cancer.

Authors:  Hiroshi Kobayashi
Journal:  Reprod Med Biol       Date:  2009-09-26

9.  Malignant transformation of residual endometriosis following hysterectomy and bilateral salpingo-oophorectomy in a female patient from a family with hereditary non-polyposis colorectal cancer.

Authors:  Yuxuan Chen; Yan Zhai; Xiaoying Jiang; Zhenyu Zhang
Journal:  Oncol Lett       Date:  2013-02-06       Impact factor: 2.967

10.  Priorities for endometriosis research: recommendations from an international consensus workshop.

Authors:  Peter A W Rogers; Thomas M D'Hooghe; Asgerally Fazleabas; Caroline E Gargett; Linda C Giudice; Grant W Montgomery; Luk Rombauts; Lois A Salamonsen; Krina T Zondervan
Journal:  Reprod Sci       Date:  2009-02-05       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.